Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

An examination of pharmaceutical supply chain for artemisinin‐based combination therapies in Ghana

An examination of pharmaceutical supply chain for artemisinin‐based combination therapies in Ghana Purpose – The purpose of this paper is to examine the pharmaceutical supply chain for artemisinin‐based combination therapies (ACT) in Ghana. Design/methodology/approach – This study employed an inductive approach in examining the dynamics of the pharmaceutical supply chain. The study also used analytical hierarchical process in identifying factors that are detrimental to the ACT supply chain. Findings – The study revealed that there are basically two main supply channels through which ACT enters the Ghanaian pharmaceutical system – private and public. The ACT network depicts a strong evidence of actor interdependence and long‐term relationships. However, the key supply chain enabler – the use of information technology – was found to be lacking, leading to delays and disruptions in the supply chain system. Disruption was found to be the main detrimental factor to the supply chain although delay was found to be occurring more frequently. Price increases indicated a low effect on the supply network at the pharmacy level, but the general price of the highly subsidised effective ACT (Coartem) remains very high. Research limitations/implications – Owing to constraints in accessibility, it was challenging to contact all the actors in the network individually, especially the consumer. Drugs considered in the study were the WHO approved ACT, even though efforts were made to compile available anti‐malarial drugs on the market. Practical implications – This study has provided insights into the supply chain for ACT. The findings of the study are relevant in improving the supply chain system. Originality/value – The paper brings to the fore the need for a proper pharmaceutical supply chain management in the health sector with regards to one of the world's most infectious and deadly diseases – malaria. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Management Research Review Emerald Publishing

An examination of pharmaceutical supply chain for artemisinin‐based combination therapies in Ghana

David Asamoah; Patience Abor; Martin Opare
Management Research Review , Volume 34 (7): 20 – Jun 21, 2011
Download PDF
20 pages

Loading next page...
 
/lp/emerald-publishing/an-examination-of-pharmaceutical-supply-chain-for-artemisinin-based-dmkcpQCTgB

References (34)

Publisher
Emerald Publishing
Copyright
Copyright © 2011 Emerald Group Publishing Limited. All rights reserved.
ISSN
2040-8269
DOI
10.1108/01409171111146689
Publisher site
See Article on Publisher Site

Abstract

Purpose – The purpose of this paper is to examine the pharmaceutical supply chain for artemisinin‐based combination therapies (ACT) in Ghana. Design/methodology/approach – This study employed an inductive approach in examining the dynamics of the pharmaceutical supply chain. The study also used analytical hierarchical process in identifying factors that are detrimental to the ACT supply chain. Findings – The study revealed that there are basically two main supply channels through which ACT enters the Ghanaian pharmaceutical system – private and public. The ACT network depicts a strong evidence of actor interdependence and long‐term relationships. However, the key supply chain enabler – the use of information technology – was found to be lacking, leading to delays and disruptions in the supply chain system. Disruption was found to be the main detrimental factor to the supply chain although delay was found to be occurring more frequently. Price increases indicated a low effect on the supply network at the pharmacy level, but the general price of the highly subsidised effective ACT (Coartem) remains very high. Research limitations/implications – Owing to constraints in accessibility, it was challenging to contact all the actors in the network individually, especially the consumer. Drugs considered in the study were the WHO approved ACT, even though efforts were made to compile available anti‐malarial drugs on the market. Practical implications – This study has provided insights into the supply chain for ACT. The findings of the study are relevant in improving the supply chain system. Originality/value – The paper brings to the fore the need for a proper pharmaceutical supply chain management in the health sector with regards to one of the world's most infectious and deadly diseases – malaria.

Journal

Management Research Review – Emerald Publishing

Published: Jun 21, 2011

Keywords: Ghana; Pharmaceuticals industry; Supply chain management; Drugs

There are no references for this article.